1. Home
  2. FMST vs HBIO Comparison

FMST vs HBIO Comparison

Compare FMST & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foremost Lithium Resource & Technology Ltd.

FMST

Foremost Lithium Resource & Technology Ltd.

HOLD

Current Price

$1.52

Market Cap

30.5M

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$5.95

Market Cap

24.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMST
HBIO
Founded
2005
1901
Country
Canada
United States
Employees
2
N/A
Industry
Other Metals and Minerals
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
30.5M
24.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
FMST
HBIO
Price
$1.52
$5.95
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.00
AVG Volume (30 Days)
82.7K
23.7K
Earning Date
05-21-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$116,176,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.38
52 Week High
$4.57
$7.50

Technical Indicators

Market Signals
Indicator
FMST
HBIO
Relative Strength Index (RSI) 44.61 47.08
Support Level $1.49 $4.57
Resistance Level $1.94 $6.85
Average True Range (ATR) 0.13 0.46
MACD -0.00 -0.03
Stochastic Oscillator 26.36 13.27

Price Performance

Historical Comparison
FMST
HBIO

About FMST Foremost Lithium Resource & Technology Ltd.

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: